日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19

布喹那和双嘧达莫联合用药在体外表现出对 SARS-CoV-2 的协同抗病毒活性:针对 COVID-19 的宿主抗病毒治疗策略的原理

James F Demarest, Maryline Kienle, RuthMabel Boytz, Mary Ayres, Eun Jung Kim, J J Patten, Donghoon Chung, Varsha Gandhi, Robert A Davey, David B Sykes, Nadim Shohdy, John C Pottage Jr, Vikram S Kumar

HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells

HIV-1 对 CCR5 拮抗剂的耐药性与 CCR5 的高效利用和原代 CD4+ T 细胞的趋向性改变有关

Jennifer M Pfaff, Craig B Wilen, Jessamina E Harrison, James F Demarest, Benhur Lee, Robert W Doms, John C Tilton

HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry

对 CCR5 拮抗剂具有基线耐药性的患者的 HIV 1 型病毒利用药物结合受体进入

John C Tilton, Heather Amrine-Madsen, John L Miamidian, Kathryn M Kitrinos, Jennifer Pfaff, James F Demarest, Neelanjana Ray, Jerry L Jeffrey, Celia C Labranche, Robert W Doms